Palisade Bio's three largest insider shareholders as of September 29, 2026 are Donald Allen Williams (Director, 1.57Mn shares), Binxian Wei (Director, 613.36K shares), Emil Chuang (Director, 612.50K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Donald Allen Williams | Director | 1,571,022 | 0 | 1,571,022 | 40.0% | 12 Jun, 2026 |
| 2 | Binxian Wei | Director | 614,210 | 0 | 614,210 | 15.6% | 12 Jun, 2026 |
| 3 | Emil Chuang | Director | 612,500 | 0 | 612,500 | 15.6% | 12 Jun, 2026 |
| 4 | Robert Jr. Baltera | Director | 461,904 | 0 | 461,904 | 11.8% | 10 Jul, 2026 |
| 5 | Jordan Michael Zwick | Director | 336,904 | 0 | 336,904 | 8.6% | 12 Jun, 2026 |
| 6 | John David Finley | Ceo, Cfo | 142,760 | 88,451 | 231,211 | 5.9% | 21 Aug, 2026 |
| 7 | Mitchell Lawrence Jones | Chief Medical Officer | 97,861 | 0 | 97,861 | 2.5% | 08 Jul, 2026 |
| 8 | Thomas Hallam | Chief Executive Officer | 1 | 0 | 1 | 0.0% | 18 Aug, 2022 |
| 9 | Michael John Dawson | Chief Medical Officer | 0 | 0 | 0 | 0.0% | 30 Mar, 2022 |
| 10 | Stephanie Diaz | Director | 0 | 0 | 0 | 0.0% | 13 Feb, 2024 |
| 11 | James R Neal | Director | 0 | 0 | 0 | 0.0% | 13 Feb, 2024 |
| 12 | Robert J. Trenschel | Director | 0 | 0 | 0 | 0.0% | 13 Feb, 2024 |
| 13 | Cristina Csimma | Director | 0 | 0 | 0 | 0.0% | 13 Feb, 2024 |
| 14 | Robert Curtis Mcrae | Chief Operating Officer | 0 | 0 | 0 | 0.0% | 05 Apr, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 19 Aug, 2026 | John David Finley | Ceo, Cfo | Disposed G | 88,400 | $0.00 | $0 | 129,288 | Direct |
| 19 Aug, 2026 | John David Finley | Ceo, Cfo | Acquired G | 88,400 | $0.00 | $0 | 88,451 | Indirect |
| 08 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 20,000 | $1.99 | $39.80K | 436,904 | Direct |
| 09 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 25,000 | $1.96 | $48.90K | 461,904 | Direct |
| 06 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 20,000 | $2.05 | $41.04K | 386,904 | Direct |
| 06 Jul, 2026 | Mitchell Lawrence Jones | Chief Medical Officer | Acquired M | 131,167 | — | — | 145,889 | Direct |
| 06 Jul, 2026 | John David Finley | Ceo, Cfo | Acquired M | 335,167 | — | — | 364,353 | Direct |
| 07 Jul, 2026 | John David Finley | Ceo, Cfo | Disposed S | 146,798 | $2.07 | $303.34K | 217,555 | Direct |
| 07 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 30,000 | $2.03 | $61.04K | 416,904 | Direct |
| 07 Jul, 2026 | Mitchell Lawrence Jones | Chief Medical Officer | Disposed S | 51,880 | $2.05 | $106.54K | 94,009 | Direct |
| 07 Jul, 2026 | John David Finley | Ceo, Cfo | Acquired M | 133 | $0.70 | $93 | 217,688 | Direct |
| 06 Jul, 2026 | Mitchell Lawrence Jones | Chief Medical Officer | Disposed M | 131,167 | $0.00 | $0 | 655,833 | Direct |
| 06 Jul, 2026 | John David Finley | Ceo, Cfo | Disposed M | 335,167 | $0.00 | $0 | 1,675,833 | Direct |
| 07 Jul, 2026 | John David Finley | Ceo, Cfo | Disposed M | 133 | $0.00 | $0 | 0 | Direct |
| 01 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 20,000 | $1.98 | $39.60K | 356,904 | Direct |
| 02 Jul, 2026 | Robert Jr. Baltera | Director | Acquired P | 10,000 | $1.98 | $19.80K | 366,904 | Direct |
| 10 Jun, 2026 | Robert Jr. Baltera | Director | Acquired A | 336,904 | — | — | 336,904 | Direct |
| 10 Jun, 2026 | Jordan Michael Zwick | Director | Acquired A | 336,904 | — | — | 336,904 | Direct |
| 10 Jun, 2026 | Emil Chuang | Director | Acquired A | 592,300 | — | — | 592,300 | Direct |
| 10 Jun, 2026 | Donald Allen Williams | Director | Acquired A | 1,498,900 | — | — | 1,509,628 | Direct |